Non-Muscle Invasive Bladder Neoplasms
10 clinical trials · Condition
◉ Watch Non-Muscle Invasive Bladder Neoplasms
| Record | Firm | Date |
|---|---|---|
| Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer (NCT05316155) | Janssen Research & Development, LLC | 2022-04-11 |
| BladMetrix Urine Test for Monitoring Recurrence in Non-Muscle Invasive Bladder Cancer (NCT07511517) | Oslo University Hospital | 2019-10-03 |
| Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent TURBK. (NCT06167356) | IRCCS San Raffaele | 2013-11-27 |
| Pre-Approval Expanded Access Study for TAR-200 Treating Physician Use (NCT06877676) | Janssen Research & Development, LLC |
Track Non-Muscle Invasive Bladder Neoplasms automatically
Every clearance here is in the API, with alerts when new ones post.